Given the clinical similarities between SARS‐CoV‐2 and anti‐MDA5‐positive DM, we hypothesized that anti‐MDA5‐positive DM may represent an autoimmune response to a viral infection and suspected that both conditions may be associated with anti‐ACE2 IgM autoantibodies. This evidence concerns the gene ACE2 and dermatomyositis.